Dr. Diego Aviles, MD

NPI: 1538182548
Total Payments
$9,318
2024 Payments
$2,043
Companies
7
Transactions
17
Medicare Patients
54
Medicare Billing
$10,892

Payment Breakdown by Category

Consulting$8,800 (94.4%)
Food & Beverage$367.65 (3.9%)
Other$150.00 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $8,800 4 94.4%
Food and Beverage $367.65 12 3.9%
Honoraria $150.00 1 1.6%

Top Paying Companies

Company Total Records Latest Year
Travere Therapeutics, Inc. $8,800 4 $0 (2024)
Alexion Pharmaceuticals, Inc. $254.37 6 $0 (2024)
Horizon Therapeutics plc $123.69 1 $0 (2023)
Alnylam Pharmaceuticals Inc. $48.94 2 $0 (2024)
Azurity Pharmaceuticals, Inc. $39.43 2 $0 (2023)
Eurofins Viracor, Inc. $31.83 1 $0 (2021)
Grifols USA, LLC $19.39 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,043 3 Travere Therapeutics, Inc. ($2,000)
2023 $3,142 3 Travere Therapeutics, Inc. ($3,000)
2022 $1,843 3 Travere Therapeutics, Inc. ($1,800)
2021 $2,080 4 Travere Therapeutics, Inc. ($2,000)
2020 $170.93 2 Alexion Pharmaceuticals, Inc. ($150.00)
2019 $38.07 2 Alexion Pharmaceuticals, Inc. ($38.07)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/05/2024 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $2,000.00 General
03/13/2024 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Food and Beverage In-kind items and services $20.85 General
Category: Genetic Disease
02/28/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $22.41 General
Category: Rare Disease
09/27/2023 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $123.69 General
Category: PROCYSBI
08/08/2023 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $3,000.00 General
03/07/2023 Azurity Pharmaceuticals, Inc. Qbrelis (Drug), Katerzia, Fleqsuvy Food and Beverage In-kind items and services $18.50 General
Category: pediatric hypertension
08/31/2022 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $23.37 General
Category: Rare Disease
05/03/2022 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $19.39 General
Category: Immunology and Neurology
04/07/2022 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $1,800.00 General
12/15/2021 Travere Therapeutics, Inc. Consulting Fee Cash or cash equivalent $2,000.00 General
12/04/2021 Eurofins Viracor, Inc. Food and Beverage Cash or cash equivalent $31.83 General
11/10/2021 Alexion Pharmaceuticals, Inc. Ultomiris (Drug) Food and Beverage In-kind items and services $20.52 General
Category: Immunology
06/08/2021 Alnylam Pharmaceuticals Inc. OXLUMO (Drug) Food and Beverage In-kind items and services $28.09 General
Category: Genetic Disease
09/15/2020 Alexion Pharmaceuticals, Inc. Ultomiris (Drug) Honoraria Cash or cash equivalent $150.00 General
Category: Immunology
09/02/2020 Azurity Pharmaceuticals, Inc. Epaned (Drug), Qbrelis, Katerzia Food and Beverage Cash or cash equivalent $20.93 General
Category: pediatric hypertension
12/04/2019 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Drug) Food and Beverage In-kind items and services $19.99 General
Category: Immunology
06/12/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $18.08 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 28 75 $19,983 $7,247
2022 1 15 18 $7,578 $1,980
2021 1 11 14 $5,894 $1,665
Total Patients
54
Total Services
107
Medicare Billing
$10,892
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 13 56 $11,872 $5,232 44.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 15 19 $8,111 $2,015 24.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 15 18 $7,578 $1,980 26.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 11 14 $5,894 $1,665 28.3%

About Dr. Diego Aviles, MD

Dr. Diego Aviles, MD is a Pediatrics healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538182548.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diego Aviles, MD has received a total of $9,318 in payments from pharmaceutical and medical device companies, with $2,043 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($8,800).

As a Medicare-enrolled provider, Aviles has provided services to 54 Medicare beneficiaries, totaling 107 services with total Medicare billing of $10,892. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Nephrology
  • Location New Orleans, LA
  • Active Since 07/25/2006
  • Last Updated 05/05/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1538182548

Products in Payments

  • Ultomiris (Drug) $170.52
  • PROCYSBI (Drug) $123.69
  • OXLUMO (Drug) $48.94
  • ULTOMIRIS (Biological) $45.78
  • Epaned (Drug) $20.93
  • ULTOMIRIS (Drug) $19.99
  • Xembify (Biological) $19.39
  • Qbrelis (Drug) $18.50
  • SOLIRIS (Drug) $18.08

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in New Orleans